TYSONS CORNER, Va., April 27, 2015 (GLOBE NEWSWIRE) -- ScripsAmerica, Inc. (OTCBB: SCRC ), a leading provider of a range of specialty prescription and over the counter pharmaceuticals and medical supplies, today announced that SeeThruEquity , a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, has issued an update to the coverage it initiated in 2014.
In its new report, SeeThruEquity believes 2015 has the potential to be a watershed year for ScripsAmerica, with revenues growing significantly over the $30 million generated in 2014. In addition to the growth anticipated in the Company's core specialty pharmacy business, both organically as well as through acquisitions, the analyst believes the Company's PIMD and Physician Dispensing Program operations will make meaningful contributions, especially over the second half of fiscal 2015. Consequently, the analyst reiterated his $1.20 per share price target.
The update report is available via the Investor Relations portion of the ScripsAmerica website. SeeThruEquity is an approved equity research contributor on Thomson First Call, Capital IQ, FactSet, and Zack's.
About ScripsAmerica, Inc.
ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com .
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether a result of new information, future events or otherwise.
Joe Hassett Gregory FCA 610-228-2110
